Robert Marshall Net Worth

The estimated Net Worth of Robert J. Jr. Marshall is at least $22 million dollars as of 15 March 2024. Mr. Marshall owns over 20,000 units of Lantheus Inc stock worth over $11,596,711 and over the last 6 years he sold LNTH stock worth over $8,959,445. In addition, he makes $1,435,390 as Chief Financial Officer et Treasurer at Lantheus Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Marshall LNTH stock SEC Form 4 insiders trading

Robert has made over 20 trades of the Lantheus Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of LNTH stock worth $1,200,000 on 15 March 2024.

The largest trade he's ever made was selling 25,441 units of Lantheus Inc stock on 6 March 2023 worth over $1,843,964. On average, Robert trades about 5,463 units every 58 days since 2018. As of 15 March 2024 he still owns at least 113,749 units of Lantheus Inc stock.

You can see the complete history of Mr. Marshall stock trades at the bottom of the page.

Robert Marshall biography

Robert J. Marshall Jr. serves as Chief Financial Officer, Treasurer of the Company effective September 24, 2018. He brings to the Company more than 30 years of finance experience, including in mergers and acquisitions, capital markets and investor relations. Prior to joining Lantheus, Mr. Marshall spent 16 years with Zimmer Biomet Holdings, Inc., a global medical device company with a leading position in musculoskeletal health. He held various senior leadership roles, including Vice President, Investor Relations and Corporate Treasurer, and most recently as Vice President, Americas Finance, for the U.S., Canadian and Latin American commercial markets. Prior to Zimmer Biomet, Mr. Marshall was employed with Brown & Williamson Tobacco, a subsidiary of British American Tobacco, p.l.c., in Louisville, Kentucky, where he held several positions of increasing responsibility. Mr. Marshall holds a Master of Business Administration from Indiana University, South Bend, and a Bachelor of Business Administration in Finance from the University of Notre Dame. He also holds the CFA designation.

What is the salary of Robert Marshall?

As the Chief Financial Officer et Treasurer of Lantheus Inc, the total compensation of Robert Marshall at Lantheus Inc is $1,435,390. There are 1 executives at Lantheus Inc getting paid more, with Mary Heino having the highest compensation of $4,320,910.

How old is Robert Marshall?

Robert Marshall is 53, he's been the Chief Financial Officer et Treasurer of Lantheus Inc since 2018. There are 16 older and 8 younger executives at Lantheus Inc. The oldest executive at Lantheus Holdings Inc is James Thrall, 76, who is the Independent Director.

What's Robert Marshall's mailing address?

Robert's mailing address filed with the SEC is C/O LANTHEUS HOLDINGS, INC., 201 BURLINGTON ROAD, SOUTH BLDG, BEDFORD, MA, 01730.

Insiders trading at Lantheus Inc

Over the last 9 years, insiders at Lantheus Inc have traded over $500,725,766 worth of Lantheus Inc stock and bought 8,000 units worth $141,200 . The most active insiders traders include David F Burgstahler, Capital Partners Gp, Llc Av... et Sriram Venkataraman. On average, Lantheus Inc executives and independent directors trade stock every 11 days with the average trade being worth of $15,777,680. The most recent stock trade was executed by James H Thrall on 21 August 2024, trading 1,000 units of LNTH stock currently worth $98,520.

What does Lantheus Inc do?

lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.

Complete history of Mr. Marshall stock trades at Lantheus Inc

Lantheus Inc executives and stock owners

Lantheus Inc executives and other stock owners filed with the SEC include:

• Mary Heino,
  President, Chief Executive Officer, Director
• Robert Marshall,
  Chief Financial Officer, Treasurer
• Mary Anne Heino,
  CEO, Pres & Director
• Michael Duffy,
  Senior Vice President, Law and Public Policy and General Counsel
• John Bolla,
  Chief Operating Officer, Senior Vice President, Technical Operations
• Simon Robinson,
  Senior Vice President - Research and Pharmaceutical Development
• Robert J. Marshall Jr., CFA,
  CFO & Treasurer
• Paul M. Blanchfield,
  Chief Operating Officer
• Daniel M. Niedzwiecki,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Brian Markison,
  Non-Executive Independent Chairman of the board
• Samuel Leno,
  Independent Director
• Frederick Robertson,
  Independent Director
• James Clemmer,
  Independent Director
• Gary Pruden,
  Independent Director
• Julie McHugh,
  Independent Director
• James Thrall,
  Independent Director
• Heinz Maeusli,
  Independent Director
• Gerard Ber,
  Independent Director
• Istvan Molnar,
  Chief Medical Officer
• Paul Blanchfield,
  Chief Commercial Officer
• Carol Walker,
  Senior Vice President - Quality
• Etienne Montagut,
  Senior Vice President - Corporate Development
• Etienne Montagut,
  Chief Bus. Officer
• Carol Walker,
  Sr. VP of Quality
• Ying Yao,
  Chief HR Officer
• Melissa Downs,
  Director of Corp. Communications
• Linda S. Lennox,
  VP of Corp. Communications & Chief of Staff
• Mark Richard Kinarney,
  Sr. Director of Investor Relations
• Andrea Sabens,
  Principal Accounting Officer
• Capital Partners Gp, Llc Av...,
  
• David F Burgstahler,
  Director
• Cesare Orlandi,
  Chief Medical Officer
• Derace L Schaffer,
  Director
• Sriram Venkataraman,
  Director
• Timothy G Healey,
  SVP, Commercial
• Daniel Niedzwiecki,
  See Remarks
• Ying Vivian Yao,
  Chief Human Resources Officer
• Minnie Baylor Henry,
  
• Andrea Sabens,
  Chief Accounting Officer
• Kenneth Pucel,
  Director
• John W. Crowley,
  VP Finance and Accounting
• John K Bakewell,
  CFO and Treasurer
• Patrick O'neill,
  Director
• William C. Jr. Dawes,
  VP Mfrg and Operations
• Jeffrey Allen Bailey,
  CEO and President
• Kimberly Brown,
  Chief Accounting Officer
• Jeffrey Humphrey,
  Chief Medical Officer
• Sam R Leno,
  
• Jean Claude Provost,
  Chief Medical Officer